dihydroergotamine has been researched along with pizotyline in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (80.00) | 18.7374 |
1990's | 3 (15.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fanchamps, A | 2 |
Fozard, JR | 1 |
Barolin, GS | 1 |
Edvinsson, L; Hardebo, JE; Owman, C; Svendgaard, NA | 1 |
Hackaday, J | 1 |
Müller-Schweinitzer, E | 2 |
Ollat, H | 1 |
Bourin, M | 1 |
Müller-Schweinitzer, E; Rosenthaler, J | 1 |
Cavanna, M | 1 |
Bousser, MG; Massiou, H | 1 |
Prusiński, A | 1 |
Edmeads, JG | 1 |
Durward, WF | 1 |
Fanchamps, A; Müller-Schweinitzer, E | 1 |
Glusa, E; Markwardt, F | 1 |
Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L | 1 |
6 review(s) available for dihydroergotamine and pizotyline
Article | Year |
---|---|
The animal pharmacology of drugs used in the treatment of migraine.
Topics: Acetaminophen; Adrenergic alpha-Antagonists; Analgesics; Animals; Aspirin; Caffeine; Clonidine; Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Muscle, Smooth; Pizotyline; Serotonin Antagonists; Sympathetic Nervous System; Synaptic Transmission; Tryptamines; Vagus Nerve; Vasoconstrictor Agents; Vasodilator Agents | 1975 |
[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
Topics: Adrenergic beta-Antagonists; Animals; Caffeine; Clonidine; Dihydroergotamine; Drug Synergism; Epinephrine; Ergotamine; Headache; Histamine; Humans; Methysergide; Mice; Migraine Disorders; Norepinephrine; Pizotyline; Serotonin | 1975 |
[Serotonin agonists and antagonists in migraine].
Topics: Benzoxepins; Contraindications; Cyproheptadine; Dihydroergotamine; Ergotamine; Histamine H1 Antagonists; Humans; Indoles; Methysergide; Migraine Disorders; Phenothiazines; Pizotyline; Receptors, Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
[Therapy of headache].
Topics: Cluster Headache; Dextropropoxyphene; Dihydroergotamine; Domperidone; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Pizotyline; Prednisolone; Prednisone; Vascular Headaches | 1989 |
Monotherapy or polytherapy in migraine.
Topics: Barbiturates; Clonidine; Dihydroergotamine; Drug Combinations; Humans; Migraine Disorders; Pizotyline | 1987 |
Migraine.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Analgesics; Calcium Channel Blockers; Chlorpromazine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Narcotics; Pizotyline | 1988 |
14 other study(ies) available for dihydroergotamine and pizotyline
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Mechanism of action of drugs currently used in the prevention of migraine].
Topics: Adrenergic beta-Antagonists; Catecholamines; Cerebrovascular Circulation; Chemical Phenomena; Chemistry; Clonidine; Dihydroergotamine; Ergotamine; Histamine Release; Humans; Kinins; Methysergide; Migraine Disorders; Pizotyline; Serotonin Antagonists | 1976 |
[Drug therapy for headache: (author's transl)].
Topics: Analgesics; Anti-Inflammatory Agents; Antidepressive Agents; Clonidine; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders; Neuralgia; Pizotyline; Sleep; Substance-Related Disorders; Tranquilizing Agents | 1977 |
Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
Topics: Animals; Arteries; Cats; Cerebral Arteries; Cyproheptadine; Dihydroergotamine; Drug Synergism; Ergotamine; Humans; In Vitro Techniques; Methysergide; Migraine Disorders; Pizotyline; Serotonin; Serotonin Antagonists; Vasoconstriction; Vasomotor System | 1978 |
Migraine. Prophylactic drugs.
Topics: Anticonvulsants; Clonidine; Cyproheptadine; Dihydroergotamine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol; Tranquilizing Agents | 1977 |
Studies on the 5-HT receptor in vascular smooth muscle.
Topics: Animals; Basilar Artery; Cattle; Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; In Vitro Techniques; Methysergide; Muscle, Smooth; Pizotyline; Receptors, Serotonin; Thiophenes | 1978 |
[Serotonin and antiserotonergic agents].
Topics: Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Pizotyline; Serotonin; Serotonin Antagonists | 1990 |
Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
Topics: Administration, Oral; Animals; Dihydroergotamine; Dogs; Injections, Intravenous; Norepinephrine; Pizotyline; Serotonin; Vasoconstriction; Veins; Yohimbine | 1987 |
[Antimigrainous agents used in maintenance treatment].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnarizine; Clonidine; Dihydroergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol | 1986 |
The management of migraine.
Topics: Clonidine; Diet; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Pizotyline; Propranolol | 1985 |
Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
Topics: Cocaine; Dihydroergotamine; Humans; In Vitro Techniques; Norepinephrine; Pizotyline; Prazosin; Receptors, Adrenergic, alpha; Receptors, Serotonin; Saphenous Vein; Vasoconstriction; Yohimbine | 1984 |
Effects on arterial receptors of ergot derivatives used in migraine.
Topics: Animals; Cattle; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Ergotamines; Humans; In Vitro Techniques; Migraine Disorders; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Pizotyline; Receptors, Adrenergic, alpha; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Vasoconstrictor Agents; Vasomotor System | 1982 |
Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
Topics: Dihydroergotamine; Femoral Artery; Femoral Vein; Humans; In Vitro Techniques; Methysergide; Pizotyline; Receptors, Serotonin; Serotonin; Vasoconstriction | 1984 |
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; Cricetinae; Dihydroergotamine; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Lisuride; Methysergide; Migraine Disorders; Piperazines; Piperidines; Pizotyline; Propranolol; Propylamines; Protein Binding; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 1997 |